Predictive Oncology rises on collaboration to advance gene therapy
30/03/2023 15:07
** Shares of med-tech co Predictive Oncology Inc POAI.O
rise 5.7% to $0.30
** POAI partners with biotech firm Integra Therapeutics to
advance gene therapy
** Says collaboration focused on pursuing a novel method to
enhance Integra Therapeutics' ability to use gene editing for
future cancer therapies
** Including session gains, stock down ~7% YTD
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Axe Compute
See all newsBrief: Axe Compute Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Axe Compute Receives $317 Million In Customer Prepayments Under Global Ai Infrastructure Contracts
Brief: Duos Technologies Signs Five-Year, 55 MW Hosting Agreements With Axe Compute Valued At Over $500 Million
Brief: Axe Compute And Duos Technologies Enter Into Agreements For 55 MW Of New Ai Data Center Capacity Across Multiple U.S. Locations
GPU capacity provider Axe Compute's Q2 revenue surges